# BHLHE22

## Overview
BHLHE22, also known as BHLHB5, is a gene that encodes a transcription factor belonging to the basic helix-loop-helix (bHLH) family. This protein plays a pivotal role in neural development and differentiation by acting primarily as a transcriptional repressor. It forms complexes with other proteins, such as the PR/SET domain protein Prdm8, to regulate gene expression critical for neural circuit formation and function (Ross2012Bhlhb5). BHLHE22 is expressed in various neuronal populations, including those in the dorsal telencephalon and dorsal root ganglia, and is essential for the differentiation of specific neuron types, such as GABAergic amacrine cells in the retina (Ross2012Bhlhb5; Dennis2019bHLH). The protein's activity in the nucleus involves binding to E-box sequences on DNA, thereby modulating transcription (Ross2012Bhlhb5). Disruption of BHLHE22 function can lead to defects in axon targeting and neural circuit development, highlighting its importance in maintaining proper neural connectivity (Ross2012Bhlhb5).

## Structure


## Function
BHLHE22, also known as BHLHB5, is a transcription factor that plays a significant role in neural development and differentiation. It functions primarily as a repressor of gene expression, forming a complex with the PR/SET domain protein Prdm8 to mediate this repression. This complex is crucial for the proper formation of neural circuits, as it represses target genes necessary for neural circuit assembly, such as Cadherin-11 (Ross2012Bhlhb5). BHLHE22 is expressed in various neurons, including those in the dorsal telencephalon and the dorsal root ganglia, where it influences the differentiation of specific neuron populations (Ross2012Bhlhb5; Dennis2019bHLH).

In the retina, BHLHE22 is required for the differentiation of GABAergic amacrine cells and cone bipolar cells, highlighting its role in retinal development (Dennis2019bHLH). The protein is active in the nucleus, where it binds to E-box sequences on DNA to modulate transcription (Ross2012Bhlhb5). The disruption of BHLHE22 function can lead to defects in axon targeting and abnormal neural circuit development, underscoring its importance in maintaining proper neural connectivity (Ross2012Bhlhb5).

## Clinical Significance
BHLHE22, also known as BHLHB5, is implicated in various diseases and conditions due to its role in gene regulation and neural development. In endometrial cancer (EC), BHLHE22 expression is significantly downregulated compared to normal endometrium, and its reduced expression is associated with increased cell proliferation and migration, contributing to poor survival outcomes. Conversely, high BHLHE22 expression correlates with favorable survival outcomes in EC patients, suggesting its potential as a prognostic marker (Darmawi2022BHLHE22).

In the context of neurological disorders, BHLHE22 is involved in cerebellar development, particularly in the differentiation and migration of granule cells. Alterations in BHLHE22 expression can affect these processes, potentially contributing to conditions such as autism spectrum disorder (ASD). The gene's expression is regulated by enhancers, and mutations or variants in these regulatory regions have been associated with ASD, highlighting a potential link between BHLHE22 dysregulation and neurodevelopmental disorders (Ramirez2022Temporal; Ramirez2021Temporal).

Overall, BHLHE22's role in both cancer and neurological development underscores its clinical significance, with potential implications for prognosis and therapeutic strategies in related diseases.

## Interactions
BHLHE22, also known as Bhlhb5, is a transcription factor that participates in several protein-protein interactions crucial for its function in gene regulation. BHLHE22 forms a repressor complex with the PR/SET domain protein Prdm8, which is essential for neuronal circuit assembly. This complex represses target genes necessary for proper neural circuit formation, such as Cadherin-11 (Cdh11). BHLHE22 binds to specific DNA elements and recruits Prdm8 to mediate transcriptional repression. The interaction between BHLHE22 and Prdm8 is critical, as the absence of either protein leads to similar phenotypic abnormalities, including axonal mistargeting and behavioral issues (Ross2012Bhlhb5).

In a different context, BHLHE22 interacts with protein arginine methyltransferase 5 (PRMT5) to form a transcriptional complex that activates the expression of colony stimulating factor 2 (CSF2). This interaction is specific, as PRMT5 does not interact with other bHLH family members. BHLHE22 binds to the CSF2 promoter, and PRMT5 acts as an epigenetic modifier, facilitating the transcriptional activation of CSF2. This interaction is significant in the context of prostate cancer, where it contributes to an immunosuppressive tumor microenvironment (Yin2023BHLHE22).


## References


[1. (Yin2023BHLHE22) Chi Yin, Min Wang, Yingzhao Wang, Qijun Lin, Kaiyuan Lin, Hong Du, Chuandong Lang, Yuhu Dai, and Xinsheng Peng. Bhlhe22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer. Journal for ImmunoTherapy of Cancer, 11(3):e005532, March 2023. URL: http://dx.doi.org/10.1136/jitc-2022-005532, doi:10.1136/jitc-2022-005532. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jitc-2022-005532)

[2. (Ross2012Bhlhb5) Sarah E. Ross, Alejandra E. McCord, Cynthia Jung, Denize Atan, Stephanie I. Mok, Martin Hemberg, Tae-Kyung Kim, John Salogiannis, Linda Hu, Sonia Cohen, Yingxi Lin, Dana Harrar, Roderick R. McInnes, and Michael E. Greenberg. Bhlhb5 and prdm8 form a repressor complex involved in neuronal circuit assembly. Neuron, 73(2):292–303, January 2012. URL: http://dx.doi.org/10.1016/j.neuron.2011.09.035, doi:10.1016/j.neuron.2011.09.035. This article has 105 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2011.09.035)

[3. (Dennis2019bHLH) Daniel J. Dennis, Sisu Han, and Carol Schuurmans. Bhlh transcription factors in neural development, disease, and reprogramming. Brain Research, 1705:48–65, February 2019. URL: http://dx.doi.org/10.1016/j.brainres.2018.03.013, doi:10.1016/j.brainres.2018.03.013. This article has 172 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.brainres.2018.03.013)

4. (Ramirez2021Temporal) Temporal analysis of enhancers during mouse brain development reveals dynamic regulatory function and identifies novel regulators of cerebellar development. This article has 1 citations.

[5. (Darmawi2022BHLHE22) Darmawi, Lin-Yu Chen, Po-Hsuan Su, Phui-Ly Liew, Hui-Chen Wang, Yu-Chun Weng, Rui-Lan Huang, and Hung-Cheng Lai. Bhlhe22 expression is associated with a proinflammatory immune microenvironment and confers a favorable prognosis in endometrial cancer. International Journal of Molecular Sciences, 23(13):7158, June 2022. URL: http://dx.doi.org/10.3390/ijms23137158, doi:10.3390/ijms23137158. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23137158)

[6. (Ramirez2022Temporal) Miguel Ramirez, Yuliya Badayeva, Joanna Yeung, Joshua Wu, Ayasha Abdalla-Wyse, Erin Yang, Brett Trost, Stephen W Scherer, and Daniel Goldowitz. Temporal analysis of enhancers during mouse cerebellar development reveals dynamic and novel regulatory functions. eLife, August 2022. URL: http://dx.doi.org/10.7554/elife.74207, doi:10.7554/elife.74207. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.74207)